NYSE:CNMDMedical Equipment
Will CONMED’s New CFO Steer CNMD’s Capital Allocation Toward Greater Discipline Or Strategic Risk?
CONMED Corporation has announced that John E. Gallagher will become Chief Financial Officer on July 15, 2026, succeeding Todd Garner, who will stay on as an advisor until November 2, 2026.
This leadership transition brings nearly three decades of healthcare-focused financial experience into CONMED’s C-suite, potentially influencing capital allocation, cost discipline, and support for its minimally invasive surgery portfolio.
We’ll now examine how bringing in an experienced healthcare CFO...